Prospective Surveillance Study of Haemophilia a Patients Switching From Moroctocog Alfa or Other Factor VIII Products to Moroctocog Alfa Albumin-Free Cell Culture (AF-CC) in Usual Care Settings

Thrombosis and Haemostasis - Germany
doi 10.1160/th14-09-0760
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B

Haemophilia
MedicineGeneticsHematology
2019English

Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
1981English

Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study

British Journal of Haematology
Hematology
2017English

Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial

Haemophilia
MedicineGeneticsHematology
2019English

Is It Worthy of Switching to PegIFN Alfa-2a in Patients Achieving Virological Suppression With Entecavir?

Journal of Hepatology
Hepatology
2015English

Molecular Design and Downstream Processing of Turoctocog Alfa (NovoEight), a B-Domain Truncated Factor VIII Molecule

Blood Coagulation and Fibrinolysis
MedicineHematology
2016English

Drotrecogin Alfa in Patients With Severe Sepsis: Experience From a Tertiary Care Center in North India

Critical Care
Critical CareIntensive Care Medicine
2007English

Interferon-Alfa in the Treatment of Patients With Inoperable Locally Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review

Canadian Urological Association Journal
Urology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy